Media coverage

Dr. Rynearson discusses the development of GSM-779690T and his work with Acta’s first Combination Therapy,…

Dr. Tanzi discusses GSM-779690T and his vision for the future of Alzheimer’s disease

Dr. Tanzi describes his SHIELD plan–Sleep, Handle Stress, Interact socially, Exercise, Learn new things and…